Loading clinical trials...

Eye-Tracking Interaction System for Non-verbal ICU Patients | Clinical Trials | Clareo Health

NOT_YET_RECRUITINGNA

Eye-Tracking Interaction System for Non-verbal ICU Patients

Application of an Eye-Tracking Interaction System for Non-verbal ICU Patients Based on Co-Design Principles: A Feasibility Randomized Controlled Trial With an Embedded Qualitative Study

NCT07205419•Shanghai Zhongshan Hospital

View on ClinicalTrials.gov

Summary

The objectives of this clinical trial are to explore the feasibility of the eye-tracking interactive system in improving communication disorders among non-verbal ICU patients. It will also preliminarily investigate the effectiveness of this system in facilitating communication for these patients. Researchers will compare the eye-tracking interactive system with traditional augmentative and alternative communication (AAC) technologies (such as body language, writing boards, etc.) to observe the feasibility and preliminary effectiveness of the eye-tracking interactive system in improving communication disorders. Participants will: * Use augmentative and alternative communication technologies daily * Have detailed records of every communication interaction

Eligibility

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Aged ≥ 18 years
•Patients in the ICU who are unable to communicate through normal verbal means due to endotracheal intubation/tracheotomy, muscle or nerve injury, acute/chronic spinal cord injury, etc.
•Richmond Agitation-Sedation Scale (RASS) score of -1 to 1;④Primary caregivers are adults
•Able to read Chinese characters and follow simple commands
•Willing to participate in this study

Exclusion Criteria

•Diseases associated with cognitive impairment, such as pulmonary encephalopathy, hepatic encephalopathy, diabetic hyperosmolar coma, and coma of unknown cause
•A history of mental disorders, dementia or pre-dementia, or intellectual disability
•Conditions precluding cooperation with eye-tracking interaction, such as blindness or inability to elevate the eyelids

Key Dates

Start Date

April 1, 2026

Primary Completion Date

March 31, 2027

Completion Date

March 31, 2027

Last Updated

October 3, 2025

Enrollment

ESTIMATED participants

Conditions

Communication BarriersEye-tracking TechnologyICU Patients

Interventions

Eye-Tracking Interaction System

DEVICE

STimulation to Activate RespIration

NCT06832306

ARDS (Moderate or Severe)AHRF+1 more

View study

RECRUITING

Evaluation of Rehabilitation Practices in the Intensive Care Unit

NCT06969443

Invasive Mechanical VentilationRehabilitation Exercise of ICU Patients

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: October 3, 2025Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Eye-Tracking Interaction System for Non-verbal ICU Patients

Inclusion Criteria

Exclusion Criteria

STimulation to Activate RespIration

Evaluation of Rehabilitation Practices in the Intensive Care Unit

Options for Lowering the Threshold to Brussels Out-of-hours Primary Care Services for Dutch Speaking Citizens

Implementation of Clinical Nutrition Practice Guidelines in Surgical ICUs

Sleep Quality of Intensive Care Patients

The Impact of POCUS on Treatment Planning and Prognosis in the ICU